Safety and efficacy of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
Hassanein, Mohamed M., Sahay, Rakesh, Hafidh, Khadija, Djaballah, Khier, Li, Haoyu, Azar, Sami, Shehadeh, Naim, Hanif, WasimLangue:
english
Journal:
Diabetes Research and Clinical Practice
DOI:
10.1016/j.diabres.2019.01.035
Date:
February, 2019
Fichier:
PDF, 820 KB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
